ThirdLaw Molecular Revenue and Competitors
Estimated Revenue & Valuation
- ThirdLaw Molecular's estimated annual revenue is currently $2.6M per year.
- ThirdLaw Molecular's estimated revenue per employee is $155,000
- ThirdLaw Molecular's total funding is $2M.
Employee Data
- ThirdLaw Molecular has 17 Employees.
- ThirdLaw Molecular grew their employee count by 13% last year.
ThirdLaw Molecular's People
| Name | Title | Email/Phone |
|---|
ThirdLaw Molecular Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is ThirdLaw Molecular?
ThirdLaw Molecular LLC has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of the Company is to create a revolutionary category of molecules that transform how diseases are diagnosed and treated – more safely and effectively.
keywords:N/A
$2M
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Blue Bell
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | N/A | N/A |
#2 | $1.6M | 18 | 0% | N/A |
#3 | $2.3M | 18 | -10% | N/A |
#4 | $1.7M | 19 | -27% | N/A |
#5 | $1.7M | 19 | 0% | N/A |